tiprankstipranks
Trending News
More News >
Capha Pharmaceuticals (FPSUF)
:FPSUF
US Market

Capha Pharmaceuticals (FPSUF) Price & Analysis

Compare
1 Followers

FPSUF Stock Chart & Stats


Financials

FPSUF FAQ

What was Capha Pharmaceuticals ’s price range in the past 12 months?
Capha Pharmaceuticals lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
    What is Capha Pharmaceuticals ’s market cap?
    Capha Pharmaceuticals ’s market cap is $64.00.
      When is Capha Pharmaceuticals ’s upcoming earnings report date?
      Capha Pharmaceuticals ’s upcoming earnings report date is Sep 01, 2025 which is in 53 days.
        How were Capha Pharmaceuticals ’s earnings last quarter?
        Capha Pharmaceuticals released its earnings results on May 28, 2025. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
          Is Capha Pharmaceuticals overvalued?
          According to Wall Street analysts Capha Pharmaceuticals ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Capha Pharmaceuticals pay dividends?
            Capha Pharmaceuticals does not currently pay dividends.
            What is Capha Pharmaceuticals ’s EPS estimate?
            Capha Pharmaceuticals ’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Capha Pharmaceuticals have?
            Capha Pharmaceuticals has 64,431,030 shares outstanding.
              What happened to Capha Pharmaceuticals ’s price movement after its last earnings report?
              Capha Pharmaceuticals reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Capha Pharmaceuticals ?
                Currently, no hedge funds are holding shares in FPSUF

                Company Description

                Capha Pharmaceuticals

                Capha Pharmaceuticals (FPSUF) is a biopharmaceutical company that specializes in the research, development, and commercialization of innovative medicines. The company operates within the healthcare sector, focusing primarily on the creation of therapeutic solutions for unmet medical needs. Capha Pharmaceuticals is committed to advancing medical science through its cutting-edge drug development programs and collaborations with leading research institutions.
                Similar Stocks
                Company
                Price & Change
                Follow
                Amgen
                Biogen
                Gilead Sciences
                Regeneron
                Vertex Pharmaceuticals
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis